The objectives of this trial are to:
- Assess the safety and tolerability of diquafosol tetrasodium ophthalmic solution versus placebo following one week of treatment in subjects undergoing photorefractive keratectomy (PRK).
- Evaluate the potential of diquafosol to accelerate corneal wound healing/re-epithelialization following PRK.